Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,28 USD | +7,69% |
|
+7,69% | -72,00% |
2023 | Ev Biologics voltooit productie van baanbrekend therapeutisch middel op basis van MSC-exosomen | CI |
2023 | EV Biologics Corp benoemt William Bossung tot directeur bedrijfsfinanciën | CI |
Omzet 2016 | 42,64 mln. 39,88 mln. | Omzet 2017 | 9,51 mln. 8,89 mln. | Marktkapitalisatie | 6,09 mln. 5,7 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -53 mln. -49,56 mln. | Nettowinst (verlies) 2017 | -7 mln. -6,55 mln. | EV/omzet 2016 | 0,69 x |
Nettoschuld 2016 | 9 mln. 8,41 mln. | Nettoschuld 2017 | 10,03 mln. 9,38 mln. | EV/omzet 2017 | 1,7 x |
K/w-verhouding 2016 |
-0,38
x | K/w-verhouding 2017 |
-0,82
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 23,58% |
1 dag | +7,69% | ||
1 week | +7,69% | ||
Lopende maand | -49,56% | ||
1 maand | -49,56% | ||
3 maanden | -60,23% | ||
6 maanden | -72,00% | ||
Lopend jaar | -72,00% |
![Extreem 0.28](/images/extremecours_fleche.png)
![Extreem 0.26](/images/extremecours_fleche.png)
![Extreem 0.26](/images/extremecours_fleche.png)
![Extreem 0.26](/images/extremecours_fleche.png)
![Extreem 0.2521](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
![Extreem 0](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 29-10-18 |
Jason Sanders
BRD | Director/Board Member | 46 | 31-08-20 |
William Bossung
BRD | Director/Board Member | - | 07-08-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 29-10-18 |
William Bossung
BRD | Director/Board Member | - | 03-12-18 |
Jason Sanders
BRD | Director/Board Member | 46 | 31-08-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-72,00% | 2,86 mln. | |
+18,36% | 48,94 mld. | |
+1,55% | 16,12 mld. | |
-16,23% | 13,8 mld. | |
-2,95% | 11,87 mld. | |
-1,29% | 7,95 mld. | |
+35,08% | 7,23 mld. | |
+5,79% | 7,27 mld. | |
+105,28% | 7,34 mld. | |
-18,11% | 6,52 mld. |